Invest now
Dr. Lal PathLabs Profit & Loss Annual
BSE: 539524 | NSE: LALPATHLAB | ISIN: INE600L01024 | Sector: Healthcare Facilities1,950.00 -4.30 (-0.22%)Updated : 11 Aug 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 2,167.26 | 1,902.10 | 1,758.49 | 1,677.24 |
| Other Net | 2.45 | 5.51 | 1.29 | -0.33 |
| Diluted Weighted Average Shares | 16.72 | 16.68 | 16.65 | 16.62 |
| Gain( Loss)on Saleof Assets | -0.92 | -2.15 | -0.22 | 0.81 |
| Depreciation/ Amortization | 161.23 | 141.58 | 143.34 | 150.19 |
| Operating Income | 595.66 | 559.30 | 468.15 | 339.64 |
| Net Income | 504.78 | 487.14 | 357.74 | 238.85 |
| Income Availableto Com Excl Extra Ord | 504.78 | 487.14 | 357.74 | 238.85 |
| Other Operating Expenses Total | 35.86 | 31.35 | 41.93 | 37.08 |
| Net Income Before Taxes | 669.09 | 624.80 | 505.45 | 343.83 |
| Minority Interest | -4.98 | -5.11 | -4.56 | -2.23 |
| Interest Exp( Inc) Net- Operating Total | 0.57 | 0.35 | 0.26 | - |
| Net Income After Taxes | 509.75 | 492.25 | 362.29 | 241.08 |
| Income Availableto Com Incl Extra Ord | 504.78 | 487.14 | 357.74 | 238.85 |
| Costof Revenue Total | 562.87 | 508.62 | 477.59 | 473.06 |
| Gross Profit | 2,200.04 | 1,952.77 | 1,749.05 | 1,543.82 |
| Interest Inc( Exp) Net- Non- Op Total | 71.89 | 62.15 | 36.23 | 3.71 |
| Unusual Expense( Income) | 30.09 | - | - | - |
| Diluted Net Income | 504.78 | 487.14 | 357.74 | 238.85 |
| DPS- Common Stock Primary Issue | 14.00 | 12.00 | 12.00 | 6.00 |
| Provisionfor Income Taxes | 159.33 | 132.55 | 143.16 | 102.75 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 504.78 | 487.14 | 357.74 | 238.85 |
| Total Revenue | 2,762.91 | 2,461.40 | 2,226.64 | 2,016.88 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 2,762.91 | 2,461.40 | 2,226.64 | 2,016.88 |
| Selling/ General/ Admin Expenses Total | 1,376.63 | 1,220.20 | 1,095.38 | 1,016.91 |
| Diluted Normalized EPS | 31.61 | 29.30 | 21.50 | 14.33 |
| Diluted EPS Excluding Extra Ord Items | 30.20 | 29.20 | 21.49 | 14.37 |
*All figures in crores except per share values
Dr. Lal PathLabs Quick Links
Dr. Lal PathLabs Dividend Dr. Lal PathLabs Bonus Dr. Lal PathLabs News Dr. Lal PathLabs AGM Dr. Lal PathLabs Rights Dr. Lal PathLabs Splits Dr. Lal PathLabs Board Meetings Dr. Lal PathLabs Key Metrics Dr. Lal PathLabs Shareholdings Dr. Lal PathLabs Balance Sheet Dr. Lal PathLabs Cashflow Dr. Lal PathLabs Q1 Results Dr. Lal PathLabs Q2 Results Dr. Lal PathLabs Q3 Results Dr. Lal PathLabs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
5,098.20+155.20(3.14%)
1,102.85+20.85(1.93%)
2,024.95+23.05(1.15%)
1,072.00-24.05 (-2.19%)
310.50-4.95 (-1.57%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.